• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Roche, Diabeloop partner on insulin pump management

December 11, 2020 By Sean Whooley

Roche (SWX: RO,  ROG) announced today that it is partnering with Diabeloop to advance insulin pump therapy management.

Basel, Switzerland-based Roche said in a news release that the partnership will create new opportunities to lower the burden of constant insulin dose adjustment for those with diabetes while also improving therapy outcomes.

Roche also said the partnership with Paris-based Diabeloop marks its first step into the field of automated insulin delivery as it continues to put forth its strategy of integrated personalized diabetes management.

“Everybody at Roche Diabetes Care is excited about the new partnership with Diabeloop. The technology of Diabeloop, based on a self-learning algorithm, is unique. We are convinced that the potential of the hybrid closed-loop systems will contribute to a more efficient and personalized approach of diabetes management,” Roche Diabetes Care global head Marcel Gmuender said in the release. “For more than three decades, we have been committed to supporting people with diabetes with a range of different insulin pump technologies. Throughout the years, we have always aimed to give people with diabetes choice, so that they can select the best therapy solutions to suit their needs. Together with Diabeloop, we are again expanding the choice of options available to people with diabetes, by embarking on our journey of automated insulin delivery.”

“Reliable insulin delivery is a critical component in Diabeloop’s hybrid closed-loop systems embedding therapeutic artificial intelligence,” added Diabeloop founder & co-CEO Erik Huneker. “The accuracy and reliability of Roche’s insulin pump portfolio perfectly fits our vision to personalize therapy to the physiology and lifestyle of people with diabetes, helping them to spend less time managing diabetes while improving time in range.”

“We are looking forward to partnering with Roche and work together to individualize diabetes management,” concluded Marc Julien, co-CEO at Diabeloop.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Diabeloop, Roche

IN CASE YOU MISSED IT

  • EmblemHealth to provide coverage for Senseonics’ Eversense CGM
  • Eitan Medical lands FDA clearance for infusion pump system upgrade
  • Senseonics announces $50M from stock offering
  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Locate Bio lands FDA breakthrough nod for bone infection device

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS